0001193125-26-174415.txt : 20260423 0001193125-26-174415.hdr.sgml : 20260423 20260423210134 ACCESSION NUMBER: 0001193125-26-174415 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260422 FILED AS OF DATE: 20260423 DATE AS OF CHANGE: 20260423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Maizel Ari CENTRAL INDEX KEY: 0002042289 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37635 FILM NUMBER: 26890200 MAIL ADDRESS: STREET 1: ONE WORLD TRDE CENTER STREET 2: 22ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Axsome Therapeutics, Inc. CENTRAL INDEX KEY: 0001579428 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 454241907 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE WORLD TRADE CENTER, 29TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10007 BUSINESS PHONE: (212) 332-3241 MAIL ADDRESS: STREET 1: ONE WORLD TRADE CENTER, 29TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10007 4 1 ownership.xml 4 X0609 4 2026-04-22 0001579428 Axsome Therapeutics, Inc. AXSM 0002042289 Maizel Ari false C/O AXSOME THERAPEUTICS, INC. ONE WORLD TRADE CENTER, 29TH FLOOR NEW YORK NY 10007 false true false false Chief Commercial Officer true Common Stock 2026-04-22 4 M false 7500 70.73 A 7500 D Common Stock 2026-04-22 4 S false 7500 182.42 D 0 D Stock Option (Right to Buy) 70.73 2026-04-22 4 M false 7500 0.00 D 2024-09-25 2033-09-25 Common Stock 7500 23710 D Such transaction was pursuant to a pre-approved 10b5-1 plan. Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options. Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $181.01 and $184.28. /s/ Ari Maizel 2026-04-23